Monday, August 4, 2025

Latest

Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement

Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their second manufacturing agreement of the year. Under the new multi year agreement, Medipharm is to fill and pack vaporizor devices for Cronos Group’s recreational brand Cove, pending approval from Health Canada.

The white label agreement is for a term of two years with an option for renewal. However little details were provided by the two firms, with no indication as to the anticipated dollar value of the transaction, whether it was an exclusive transaction, or how many devices are anticipated to be filled and packaged by Medipharm Labs on an annual basis.

By leveraging our specialized expertise, technology and industrial scale vape filling capabilities, we will assist Cronos Group in delivering high quality, purity assured and Health Canada approved, derivative products further advancing their industry leading reputation and enhancing the supply chain in this important new category.

Pat McCutcheon, CEO of MediPharm Labs

The lack of details for the recently signed manufacturing agreement is in stark contrast to the agreement announced in May, which is for an anticipated $30 million over the first 18 months. That agreement has the option to expand to $60 million via certain renewal and purchase options included within the transaction. The initial manufacturing agreement was for bulk resin supply as well as tolling.

The latest agreement is subject to Health Canada’s approved of the “recreation 2.0” vaporizer devices.

Medipharm Labs closed yesterdays session at $4.93 on the Toronto Stock Exchange.


Information for this briefing was found via Sedar, Medipharm Labs and Cronos Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

San Dimas: First Majestic Silver’s Sleeper Asset

New Gold Q2 Earnings: Record Free Cash Flow

STLLR Gold: The Tower Gold PEA

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Cronos Group Sees CEO Retire, Gorenstein Returns To Helm

After less than two years on the job, Kurt Schmidt has retired as the chief...

Monday, March 21, 2022, 08:32:05 AM

Medipharm Labs: Canaccord Lowers Targets After Earnings

On August 16, Medipharm Labs (TSX: LABS) reported their second quarter financial results. The company...

Friday, August 20, 2021, 07:54:00 AM

Cronos Group Doesn’t Expect To File Delayed Financials Until The End Of January 2022

It appears that money is no substitute for ability. Cronos Group (TSX: CRON) on Friday...

Monday, December 20, 2021, 09:17:51 AM

Cronos Group Further Delays Filings, Reduces Prior Revenue Figures By $7.6 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) announced this evening that further to it’s previous release,...

Tuesday, March 17, 2020, 05:18:09 PM

Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board

This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its...

Wednesday, May 6, 2020, 09:18:25 AM